Literature DB >> 13636530

Relative effectiveness of various components of electroconvulsive therapy; an experimental study.

N Q BRILL, E CRUMPTON, S EIDUSON, H M GRAYSON, L I HELLMAN, R A RICHARDS.   

Abstract

Keywords:  SHOCK THERAPY, ELECTRIC

Mesh：

Year:  1959        PMID： 13636530     DOI： 10.1001/archneurpsyc.1959.02340170093010

Source DB:  PubMed          Journal:  AMA Arch Neurol Psychiatry        ISSN： 0096-6886


× No keyword cloud information.
  6 in total

1.  Is Conduct of Research in Electroconvulsive Therapy Ethical?

Authors:  N A Youssef; W V McCall
Journal:  J Psychol Neuropsychiatr Disord Brain Stimul       Date:  2016-05-13

2.  Simulated Electroconvulsive Therapy: A Novel Approach to a Control Group in Clinical Trials.

Authors:  Kaitlin R McManus; Maria I Lapid; Brent P Forester; Martina Mueller; Adriana P Hermida; Louis Nykamp; David G Harper; Stephen J Seiner; Sohag Sanghani; Regan Patrick; Melanie T Gentry; Simon Kung; Janette C Leal; Emily K Johnson; Georgios Petrides
Journal:  J ECT       Date:  2022-03-01       Impact factor: 3.692

Review 3.  Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT.

Authors:  Nancy A Payne; Joan Prudic
Journal:  J Psychiatr Pract       Date:  2009-09       Impact factor: 1.325

4.  Position statement and guidelines on unmodified electroconvulsive therapy.

Authors:  Chittaranjan Andrade; N Shah; P Tharyan; M S Reddy; M Thirunavukarasu; R A Kallivayalil; R Nagpal; N K Bohra; A Sharma; E Mohandas
Journal:  Indian J Psychiatry       Date:  2012-04       Impact factor: 1.759

5.  Electroconvulsive therapy for treatment-resistant schizophrenia.

Authors:  Diarmid Jm Sinclair; Sai Zhao; Fang Qi; Kazare Nyakyoma; Joey Sw Kwong; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2019-03-19

Review 6.  A critique of narrative reviews of the evidence-base for ECT in depression.

Authors:  C F Meechan; K R Laws; A H Young; D M McLoughlin; S Jauhar
Journal:  Epidemiol Psychiatr Sci       Date:  2022-01-27       Impact factor: 6.892
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.